Standardized in vitro senescence model for screening senolytics in human intervertebral disc cells
In this abstract, a combined TLR-2 activation and tBHP exposure induced senescence in three human intervertebral disc cell types, and a metabolic activity assay was validated against β-galactosidase and p16 readouts for three known senolytics. [1]
Automatic summary · not editorially reviewed
The key findings
The authors developed a standardized senescence-induction model using primary human intervertebral disc cells and combined TLR-2 activation with tert-butyl hydroperoxide. [1]
The combined exposure produced a senescent phenotype in all three disc cell types, with outer annulus fibrosus cells showing the strongest increases in the measured markers. [1]
The metabolic activity assay identified a window in which three known senolytics were non-toxic to non-senescent cells while reducing metabolic activity in a mixed population, correlating with lower β-galactosidase activity and p16 expression. [1]
The source at a glance
- Study type / format
- In vitro cell-culture methods study (abstract)
- Population / context
- Primary human intervertebral disc cells: nucleus pulposus, inner annulus fibrosus and outer annulus fibrosus cells.
- Summary based on
- Study abstract
- Publication status
- Preprint · peer-review status not confirmed
- Original publication
- August 21, 2026
Senescence model in three disc cell types
The authors state that cellular senescence contributes to age-related musculoskeletal diseases and that senolytic translation has been hindered by a lack of scalable, physiologically relevant in vitro screening. They built a standardized senescence-induction model using primary human intervertebral disc cells, combining TLR-2 activation (Pam2CSK4) with tert-butyl hydroperoxide, a reactive oxygen species generator, to mimic inflammatory and oxidative stress. Induction was checked by β-galactosidase fluorescence, β-galactosidase enzymatic activity and p16 expression in nucleus pulposus, inner annulus fibrosus and outer annulus fibrosus cells.
Supporting source [1]
Metabolic assay compared with β-gal and p16
The combined exposure produced a senescent phenotype in all three cell types, with outer annulus fibrosus cells showing the strongest increases in the three markers. Using outer annulus fibrosus cells, the authors tested whether the Alamar Blue metabolic activity assay could capture both cytotoxicity in non-senescent cells and senolytic activity in a mixed senescent and non-senescent population. They compared metabolic activity with β-galactosidase activity and p16 expression in induced and non-induced cells after exposure to three known senolytics: o-Vanillin, RG-7112 and ABT-199. The assay identified a window in which the senolytics were non-toxic to non-senescent cells while reducing metabolic activity in the mixed population, and these reductions correlated with lower β-galactosidase activity and p16 expression.
Supporting source [1]
Abstract-only scope of this screening platform
This record is an abstract; the full text was not reviewed. The work is an in vitro cell-culture study, not a human trial, so the results describe assay performance in cultured disc cells and do not establish clinical benefit or effects on human lifespan. The abstract does not report sample sizes per donor, replication numbers, statistical details or whether the workflow was tested in cell types other than intervertebral disc cells, although the authors say it applies to many other cell types.
Supporting source [1]
How to interpret this
Abstract only; the full text was not reviewed. This is an in vitro cell-culture study, not a human trial, so no clinical benefit or lifespan effect is shown. Donor numbers, replication counts and statistical details are not reported in the abstract.
Based on the study abstract; the full paper, tables and supplementary data were not reviewed.
Source & supporting passages
Cherif H, Alsabri S, Ouellet JA, Haglund L. · europepmc.org · August 21, 2026